|
Catalog Number ASKU |
Device Problem
Incorrect Or Inadequate Test Results (2456)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 02/16/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
This event occurred in (b)(6).
|
|
Event Description
|
The customer stated that they performed a comparison study for 30 patient samples tested for cortisol and cortisol ii on an e170 analyzer.The customer was questioning results for one sample in particular, since there was a large result difference between the two assays.Of the provided data, a total of eleven patient samples had erroneous results that were reported outside of the laboratory for cortisol.The cortisol results were reported outside of the laboratory and the results from the cortisol ii assay were believed to be correct.The cortisol ii assay is not sold in the united states, nor is it like or similar to products sold in the united states.The first patient serum sample initially resulted as 13.7 ug/dl when tested with cortisol.The sample resulted as 8.95 ug/dl when tested with cortisol ii.The second patient serum sample initially resulted as 10.3 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 5.42 ug/dl when tested with cortisol ii.The third patient serum sample initially resulted as 16.78 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 10.85 ug/dl when tested with cortisol ii.The fourth patient saliva sample initially resulted as 2.96 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 0.54 ug/dl when tested with cortisol ii.The fifth patient saliva sample initially resulted as 6.73 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 2.8 ug/dl when tested with cortisol ii.The sixth patient saliva sample initially resulted as 4.13 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 1.7 ug/dl when tested with cortisol ii.The seventh patient saliva sample initially resulted as 3.67 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 1.78 ug/dl when tested with cortisol ii.The eighth patient saliva sample initially resulted as 5.67 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 2.59 ug/dl when tested with cortisol ii.The ninth patient saliva sample initially resulted as 14.7 ng/ml when tested with cortisol on (b)(6) 2016.The sample resulted as 9.49 ug/dl when tested with cortisol ii.The tenth patient serum sample initially resulted as 25.45 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 16.34 ug/dl when tested with cortisol ii.The eleventh patient serum sample initially resulted as 27.24 ug/dl when tested with cortisol on (b)(6) 2016.The sample resulted as 17.61 ug/dl when tested with cortisol ii.The patients were not adversely affected.The e170 analyzer serial number was asked for, but not provided.Investigations have determined that an old cortisol calibration was in use at the time of the event.No general reagent issue was detected.
|
|
Manufacturer Narrative
|
Investigations state that with the launch of the cortisol ii assay, the formerly used polyclonal antibody was replaced by a monoclonal antibody, which is more specific and shows a lower cross-reactivity profile.The cortisol ii assay is also standardized against different reference material, which ensures accurate results.This standardization is the reason that a shift in patient results will be observed when switching from cortisol to cortisol ii.
|
|
Search Alerts/Recalls
|
|
|